Neuroleptic malignant syndrome induced by a single injection of haloperidol.
作者信息
Konikoff F, Kuritzky A, Jerushalmi Y, Theodor E
出版信息
Br Med J (Clin Res Ed). 1984 Nov 3;289(6453):1228-9. doi: 10.1136/bmj.289.6453.1228-d.
Abstract
摘要
相似文献
1
Neuroleptic malignant syndrome induced by a single injection of haloperidol.单次注射氟哌啶醇所致的神经阻滞剂恶性综合征。
Br Med J (Clin Res Ed). 1984 Nov 3;289(6453):1228-9. doi: 10.1136/bmj.289.6453.1228-d.
2
Resolution of neuroleptic malignant syndrome with dantrolene sodium: case report.用丹曲林钠治疗抗精神病药恶性综合征：病例报告
J Clin Psychiatry. 1985 Jun;46(6):244-6.
3
Relationship between neuroleptic malignant syndrome and malignant hyperthermia.抗精神病药恶性综合征与恶性高热之间的关系。
Am J Psychiatry. 1985 Mar;142(3):390. doi: 10.1176/ajp.142.3.390a.
4
Dopamine agonists and neuroleptic malignant syndrome.
Am J Psychiatry. 1985 Feb;142(2):270-1. doi: 10.1176/ajp.142.2.270b.
5
Recurrent neuroleptic malignant syndrome due to tiapride and haloperidol: the possible role of D-2 dopamine receptors.由硫必利和氟哌啶醇引起的复发性神经阻滞剂恶性综合征：D-2多巴胺受体的可能作用。
J Nerv Ment Dis. 1984 Nov;172(11):692-5. doi: 10.1097/00005053-198411000-00008.
6
Neuroleptic malignant syndrome.抗精神病药恶性综合征
Ann Emerg Med. 1985 Apr;14(4):354-8. doi: 10.1016/s0196-0644(85)80104-9.
7
Neuroleptic malignant syndrome in a trauma patient.一名创伤患者的抗精神病药恶性综合征
J Trauma. 1995 Oct;39(4):796-8. doi: 10.1097/00005373-199510000-00038.
8
Dantrolene--a new therapeutic approach to the neuroleptic malignant syndrome.丹曲林——治疗抗精神病药恶性综合征的一种新方法。
Acta Neurol Scand Suppl. 1984;100:193-8.
9
Neuroleptic malignant syndrome.抗精神病药恶性综合征
Cent Afr J Med. 1990 May;36(5):141-3.
10
Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndrome.早期碳酸氢盐负荷及丹曲林治疗齐拉西酮/氟哌啶醇所致的抗精神病药恶性综合征
J Clin Psychiatry. 2006 Apr;67(4):677. doi: 10.4088/jcp.v67n0420e.
引用本文的文献
1
[Neuroleptic malignant syndrome].[抗精神病药恶性综合征]
Nervenarzt. 2018 Mar;89(3):300-310. doi: 10.1007/s00115-017-0463-3.
2
[Prolonged neuroleptic malignant syndrome after Haloperidol injection].[氟哌啶醇注射后出现的持续性神经阻滞剂恶性综合征]
Med Klin Intensivmed Notfmed. 2018 Apr;113(3):212-216. doi: 10.1007/s00063-017-0325-6. Epub 2017 Jul 27.
3
Pharmacological management of agitation in emergency settings.急诊环境中激越的药物治疗
Emerg Med J. 2003 Jul;20(4):339-46. doi: 10.1136/emj.20.4.339.
4
Methyl p-hydroxybenzoate (E-218) a preservative for drugs and food is an activator of the ryanodine receptor Ca(2+) release channel.对羟基苯甲酸甲酯（E-218）是一种药物和食品防腐剂，是兰尼碱受体钙释放通道的激活剂。
Br J Pharmacol. 2000 Sep;131(2):335-41. doi: 10.1038/sj.bjp.0703571.
5
Neuroleptic malignant syndrome. Recognition, prevention and management.抗精神病药恶性综合征。识别、预防与处理
Drug Saf. 1998 Jul;19(1):73-82. doi: 10.2165/00002018-199819010-00006.
6
Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.丹曲林。对其药效学、药代动力学特性以及在恶性高热、抗精神病药物恶性综合征中的治疗用途的综述，并更新其在肌肉痉挛中的应用。
Drugs. 1986 Aug;32(2):130-68. doi: 10.2165/00003495-198632020-00003.
7
Neuroleptic malignant syndrome: a case report with post-mortem brain and muscle pathology.抗精神病药恶性综合征：一例伴有尸检脑和肌肉病理学检查的病例报告
J Neurol Neurosurg Psychiatry. 1989 Aug;52(8):1006-9. doi: 10.1136/jnnp.52.8.1006.
本文引用的文献
1
The neuroleptic malignant syndrome.抗精神病药恶性综合征
Arch Intern Med. 1982 Jun;142(6):1183-5.
Zotero 插件